Fosun Pharma unit to form tie-up with BioNTech for vaccine doses
A unit of a Chinese giant Shanghai Fosun Pharmaceutical has agreed a $200 million joint-venture with Germany’s BioNTech to make coronavirus vaccines, according to a company filing.
by ·
A unit of a Chinese giant Shanghai Fosun Pharmaceutical has agreed a $200 million joint-venture with Germany’s BioNTech to make coronavirus vaccines, according to a company filing.
by · Published April 12, 2021
by · Published May 27, 2021
by · Published June 8, 2021